European Medicines Agency Validates Bristol Myers Squibb's Application for Zeposia for the Treatment of Ulcerative Colitis Biotech Investing
Algernon Pharmaceuticals Announces Last Patient Out in Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19 Biotech Investing
Bioharvest Sciences Inc. and Batory Foods Announce the First Significant B2B VINIA Sale in the US Biotech Investing
IMBRUVICA® U.S. Prescribing Information Updated to Include Long-Term Data for Waldenström's Macroglobulinemia Biotech Investing
Bristol Myers Squibb Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed MGMT-Methylated Glioblastoma Multiforme Biotech Investing
